| Literature DB >> 23228357 |
Bradford D Gessner1, Oumarou Sanou, Aly Drabo, Tsidi Agbeko Tamekloe, Seydou Yaro, Haoua Tall, Jennifer C Moïsi, Judith E Mueller, Berthe-Marie Njanpop-LaFourcade.
Abstract
We evaluated pneumococcal serotype/group distribution using polymerase chain reaction (PCR) testing on cerebrospinal fluid collected from patients from Burkina Faso and Togo who presented for care during 2007-2009. We identified 282 pneumococcal meningitis cases based on PCR, latex agglutination, or culture, of which 206 underwent serotyping. Serotype 1 was identified for 18% of serotyped cases from patients aged <5 years and 66% of those aged ≥5 years. The 13-valent and 10-valent pneumococcal conjugate vaccines (PCV-13 and PCV-10) contain 53% of serotypes identified among children age <5 years and 76-77% among persons aged ≥5 years. Pneumococcal meningitis was highly seasonal regardless of serotype. Data from this study emphasize the potential usefulness of PCVs among older children and adults.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23228357 DOI: 10.1016/j.vaccine.2012.10.052
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641